Fibroblast Activity 101: The Cells That Build Our Skin

Fibroblast Activity 101: The Cells That Build Our Skin

Skin doesn't age because you're "losing collagen." It ages because fibroblasts, the cells that make collagen, start doing less of it. Every fiber of collagen, every strand of elastin, every piece of the scaffolding that keeps skin firm and dense traces back to one type of cell doing the actual construction work. Most skincare conversations skip straight to the finished product (collagen) and never mention the factory that builds it. That's the gap this piece closes.

That distinction is the whole story of perimenopause and menopause skin changes: as estrogen declines, the signal that tells fibroblasts to keep building weakens, and output drops measurably — a hormonal shift layered on top of ordinary cellular aging. Understanding what fibroblasts actually do, and exactly what causes their activity to change, gets you past the marketing shorthand and to the real mechanism behind how skin structure changes with age.

What Fibroblasts Do to Build Skin Elasticity

Fibroblasts live throughout the dermis and are responsible for synthesizing collagen, elastin, and the proteoglycans that hold moisture in skin.¹ They also produce enzymes that break down old or damaged collagen, making fibroblasts responsible for both sides of skin’s ongoing renewal process: building new structural material and clearing out what no longer serves the tissue well. In healthy, younger skin, this building and clearing process stays roughly balanced, keeping the collagen matrix dense and well organized.

Why Fibroblast Activity Slows With Age — and Collagen Loss Follows

Fibroblast activity doesn’t decline uniformly or randomly. Estrogen is a significant driver of fibroblast activity, since estrogen receptors sit directly on fibroblasts and estrogen actively signals these cells to increase collagen production while suppressing the enzymes that break collagen down.² As estrogen declines during perimenopause and drops further after menopause, that signal weakens substantially, and fibroblasts simply produce less new collagen than they once did.

Fibroblasts also undergo a process called cellular senescence as we age, where cells lose some of their normal functional capacity over time, independent of hormone levels.³ This is part of why skin aging reflects both a hormonal component and a separate, slower cellular aging component happening at the same time.

How Fibroblast Activity Is Measured

Researchers can track fibroblast output directly by measuring procollagen type I, the precursor molecule fibroblasts produce before it’s processed into mature collagen. This measurement gives a much more direct signal of fibroblast activity than simply looking at total collagen content, since it reflects new production rather than existing collagen that may have built up over years. In one clinical trial, procollagen type I increased by 65% in women taking a specific bioactive collagen peptide, VERISOL®, studied at a 2.5 gram daily dose, compared to placebo, a striking sign of renewed fibroblast activity.⁴

What Supports Fibroblast Function (and Skin Elasticity)

Since fibroblasts respond to specific molecular signals, not just general “nutrition,” the research on supporting them focuses on precise inputs. Certain collagen-derived peptides, including a compound called prolyl-hydroxyproline, have been shown in laboratory studies to directly stimulate fibroblast proliferation and activity, offering a pathway to support collagen production that works somewhat independently of estrogen levels.⁵ This matters specifically for the years when estrogen naturally declines, since it gives fibroblasts an additional signal to keep building even as their primary hormonal signal fades.

Collagen Loss Isn't the Real Story — Fibroblast Activation Is

Most conversations about skin aging focus on collagen as if it were a static substance you either have or don’t. Fibroblasts reframe that conversation entirely. Collagen isn’t static. It’s the ongoing output of living cells that can be more active or less active depending on the signals they receive. Supporting fibroblast function, rather than simply trying to add collagen from the outside, is the more accurate way to think about what actually keeps skin structurally healthy over time.

1. Managing menopausal skin changes: a narrative review. PMC. pmc.ncbi.nlm.nih.gov/articles/PMC12374573.
2. Beneficial regulation of type I collagen and matrix metalloproteinase-1 expression by estrogen, progesterone, and its combination in skin fibroblasts. GeroScience. pmc.ncbi.nlm.nih.gov/articles/PMC3456089.
3. Topical and systemic skin aging interventions: evidence, pitfalls and perspectives. ScienceDirect. 2026.
4. Proksch E, Schunck M, Zague V, Segger D, Degwert J, Oesser S. Oral intake of specific bioactive collagen peptides reduces skin wrinkles and increases dermal matrix synthesis. Skin Pharmacol Physiol. 2014;27(3):113–119.
5. Ohara H, Ichikawa S, Matsumoto H, Akiyama M, Fujimoto N. Collagen-derived dipeptide, proline-hydroxyproline, stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts. J Dermatol. 2010;37(4):330–338.
Back to blog